Vir Biotechnology, Inc.
- Last sale
- Nov 12, 2026 · -7.85%
- Market cap
- $2.07B
- 171.27M shares
- Filings
- 811
Q3 2026−7.6% FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026derivedN/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026+4.1% FY25 yoy
- $2.07B
- —
- 6.8×
- 2.3×
- -6.85%
- —
Twelve months to Sep 30, 2026 · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $68,556,000 | reported | |
| FY 2024 | 2024-12-31 | $74,205,000 | reported | |
| FY 2023 | 2023-12-31 | $86,180,000 | reported | |
| FY 2022 | 2022-12-31 | $1,615,797,000 | reported | |
| FY 2021 | 2021-12-31 | $1,095,415,000 | reported | |
| FY 2020 | 2020-12-31 | $76,368,000 | reported | |
| FY 2019 | 2019-12-31 | $8,091,000 | reported | |
| FY 2018 | 2018-12-31 | $10,668,000 | reported | |
| FY 2017 | 2017-12-31 | $2,708,000 | reported |
Segments
Products
LineFY2025ShareChange
Profit-sharing amount constrained$0.00—N/M
Profit-sharing amount previously constrained, released$0.00——
License and collaboration revenue-$1.14M—N/M
Profit-sharing amount-$1.14M—N/M
Collaboration revenue———
Contract Revenue———
License———
Total$68.56M
Biological products, except diagnostic substances
Vir Biotechnology, Inc. is the 39th largest of the 176 covered companies the SEC files under this code, by revenue. SIC 2836
CompanyRevenueGrowthNet marginMarket cap
FDMT4D Molecular Therapeutics, Inc.$85.2M230,194.6%164.4%$682.1MMGTXMeiraGTx Holdings plc$81.4M144.6%140.3%$858.1MAUTLAutolus Therapeutics plc$75.4M644.9%381.4%$318.3MRXRXRecursion Pharmaceuticals, Inc.$74.7M26.9%863.4%$2.1BCLLSCellectis S.A.$72.9M75.8%92.7%—CGENCompugen Ltd$72.8M161.1%48.6%$200.5MBDTXBlack Diamond Therapeutics, Inc.$70.0M—32.0%$86.8M
VIRVir Biotechnology, Inc. (this company)$68.6M7.6%638.9%$2.1B
CSBRChampions Oncology, Inc.$59.4M4.4%2.0%$76.4MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Vir Biotechnology, Inc. · CIK 1706431 · Engraved from SEC EDGAR